Answers are grounded in this paper and cite their sources.
This experience reports on outcomes of extreme liver surgery in selected malignancies, suggesting a need for clearer criteria and standards.
To the Editor, We read with interest the single-center experience reporting ante situm and ex situ liver resections for otherwise unresectable hepatic and perihepatic tumors[1]. The authors demonstrate that, in a highly specialized environment, these procedures can be undertaken with acceptable perioperative mortality and encouraging survival in selected primary malignancies. As transplant oncology and multimodal strategies continue to redefine therapeutic boundaries, the positioning of extreme liver surgery warrants critical reappraisal. First, strategy selection in metastatic disease remains insufficiently clarified. The absence of long-term survival in colorectal liver metastases (CRLM) despite R0 rates comparable to primary tumors indicates that technical clearance alone does not ensure durable oncologic benefit. While transplantation was not considered a primary option, key determinants of pathway assignment, including tumor burden, distribution, and depth of systemic therapy response, are not reported for the CRLM subgroup. Without these variables, early failure cannot be distinguished from adverse tumor biology versus allocative pathway choice. In an era in which transplant-based protocols have demonstrated survival in carefully selected unresectable CRLM, interpretation of extreme resection outcomes requires transparent criteria defining which patients are excluded from alternative strategies[2]. A reproducible allocation framework would materially enhance clinical interpretability and external validity. Second, outcome reporting is centered on overall survival and recurrence, whereas extreme liver surgery is fundamentally dependent on the durability of complex vascular and biliary reconstructions. Vascular patency, biliary integrity, time to reconstruction-related intervention, and longitudinal hepatic functional recovery are central determinants of net clinical benefit[3]. The inclusion of rescue liver transplantation further modifies the apparent perioperative risk and long-term survival profile. Analyses stratified by rescue transplantation and reporting of reconstruction durability endpoints would allow readers to distinguish technical success from sustained physiologic efficacy, and to judge generalizability to centers without equivalent transplant infrastructure. Third, technique-based grouping may obscure the principal drivers of outcome. Ante situm and ex situ encompass heterogeneous combinations of ischemic exposure, reconstructive extent, and parenchymal sacrifice[4]. Identical R0 rates accompanied by divergent recurrence patterns suggest that margin status alone inadequately captures biologic risk. A parsimonious stratification model incorporating reconstructive burden and core oncologic variables would offer a more transferable basis for patient selection than operative designation alone[5]. Beyond indication and reporting, a broader evaluative question emerges. As transplant-based strategies expand and systemic therapy advances, justification for highly complex resection must extend beyond feasibility within a single expert program. It should demonstrate incremental value relative to competing pathways in oncologic durability, functional preservation, and responsible use of specialized resources. Prospective, strategy-level comparisons and harmonized reporting standards across transplant and resection programs may be necessary to define this value. In summary, this experience confirms technical capability within a specialized setting. The next step for the field is to align operative ambition with reproducible selection criteria and durability-focused outcome standards. Only then can extreme liver surgery assume a clearly delineated role within contemporary surgical oncology. Ethical approval Not applicable. Consent Consent waived due to retrospective anonymized data.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: